Oncological Outcomes and Prognostic Factors of Platinum‐Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum‐Based Chemotherapy Alone: A Propensity Score–Matched Analysis in a Real‐World Population

International Journal of Urology · Published 2026-07-31 · DOI 10.1111/iju.70584

Free full text

Authors (21)

Yuto Matsushita, Yuki Kita, Shoichioro Mukai, Akira Joraku, Ikuo Kobayashi, Kei Daizumoto, Tomoyasu Sano, Shotaro Nakanishi, Jun Watanabe, Shingo Hatakeyama, Akihiro Goriki, Tatsuya Hazama, Naotaka Nishiyama, Keiichiro Mori, Hiroshi Kitamura, Takahiro Kimura, Yoshiyuki Matsui, Makito Miyake, Takashi Kobayashi, Teruo Inamoto, the Japanese Urological Oncology Group

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Matsushita, Y., Kita, Y., Mukai, S., et al. (2026). Oncological Outcomes and Prognostic Factors of Platinum‐Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum‐Based Chemotherapy Alone: A Propensity Score–Matched Analysis in a Real‐World Population. International Journal of Urology. https://doi.org/10.1111/iju.70584

Related articles